Adnan KhanAdnanProduct & AI
San Francisco Bay Area
Get in touch

Source note3 min read

Scaling Up Formal Representation of Clinical Trial Protocols in Ensemble Logic Using LLMs: A Preliminary Study

Source

arXiv

arxiv.org/abs/2607.21307v1

Read the source

Source

Plain-Language Brief

Researchers propose a pipeline called CT-TEL that uses Large Language Models (LLMs) to convert narrative clinical trial protocols into a format called Temporal Ensemble Logic (TEL). This conversion allows for automated reasoning, cohort discovery, and trial simulation. The researchers tested the system on 23 real-world trials and found that the semantic retention of the converted texts suggests that LLMs could be used to map informal protocols to computable logic.

What the Document Says

  • The reliance on unstructured free text for clinical trial protocols creates a barrier to automated reasoning, cohort discovery, and trial simulation due to the lack of formal structure.
  • Temporal Ensemble Logic (TEL) offers an expressive framework for modeling temporal phenotypes such as dynamic eligibility criteria and event timing constraints.
  • Manual encoding in TEL remains a bottleneck.
  • The CT-TEL workflow is a scalable pipeline that uses LLMs to translate narrative clinical protocols into TEL formulas.
  • The researchers applied CT-TEL to 23 real-world trials from ClinicalTrials.gov.
  • They evaluated translation fidelity via a back-translation approach, converting TEL formulas back into natural language and measuring semantic similarity against source texts.
  • The resulting semantic retention suggests that LLMs may offer a pathway for mapping informal protocols to computable logic.
  • This could lead to scalable clinical trial emulation within the 'Symbolic Biomedicine' paradigm.

Key Concepts Mentioned

  • clinical trial protocols
  • Temporal Ensemble Logic (TEL)
  • Large Language Models (LLMs)
  • automated reasoning
  • cohort discovery
  • trial simulation
  • semantic retention

Claims Made by the Document

  • The reliance on unstructured free text for clinical trial protocols creates a significant barrier to automated reasoning, cohort discovery, and trial simulation.
  • TEL offers an expressive framework for modeling temporal phenotypes.
  • Manual encoding in TEL is a bottleneck.
  • CT-TEL can translate narrative clinical protocols into TEL formulas.
  • The semantic retention of the converted texts suggests that LLMs could be used to map informal protocols to computable logic.
  • This could lead to scalable clinical trial emulation.

Evidence Used

  • The text describes the challenges with unstructured free text for clinical trial protocols and the expressive nature of TEL.
  • The text discusses manual encoding as a bottleneck and the introduction of CT-TEL as a solution.
  • The text explains the back-translation approach used to evaluate translation fidelity and the semantic retention results.
  • The text mentions the potential for scalable clinical trial emulation.

Methods / Approach

UNKNOWN

Limitations Stated by the Authors

UNKNOWN

Limitations Noted by the Agent

Agent interpretation — not from the source.

UNKNOWN

Open Questions

UNKNOWN

Notes for Future Q&A

May include interpretation. Labeled where it does.

UNKNOWN

Raw Abstract / Excerpt

The reliance on unstructured free text for documenting clinical trial protocols creates a significant barrier to automated reasoning, cohort discovery, and trial simulation. The lack of formal structure obscures critical temporal phenotypes, such as dynamic eligibility criteria and event timing constraints. Although Temporal Ensemble Logic (TEL) offers an expressive framework for modeling these elements, manual encoding remains a prohibitive bottleneck. We introduce the CT-TEL workflow: a scalable pipeline leveraging Large Language Models (LLMs) to translate narrative clinical protocols into TEL formulas. We applied CT-TEL to generate logical models for 23 real-world trials from ClinicalTrials.gov. We evaluated translation fidelity via a back-translation approach, using LLMs to convert TEL formulas back into natural language and measuring semantic similarity against source texts. The resulting semantic retention suggests that LLMs may offer a pathway for mapping informal protocols to computable logic, providing preliminary evidence toward scalable clinical trial emulation within the emerging 'Symbolic Biomedicine' paradigm championed by the corresponding author.